Caroline Schinke

54PUBLICATIONS
130CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical virologyCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (54)

|Aug 22, 2026
Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma.

|Aug 07, 2026
Correction: Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients.

|Aug 06, 2026
Talquetamab in patients with relapsed/refractory multiple myeloma: 3-year follow-up of the phase 1/2 MonumenTAL-1 study.

|Jul 28, 2026
Efficacy and Safety of CAR-T Cell Therapy and Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma with Renal Impairment: A Propensity Score-Matched Analysis.

|Jul 21, 2026
Efficacy and Safety of BCMA-Targeted Therapies in Relapsed or Refractory AL Amyloidosis: A Descriptive Pooled Analysis.

|Jun 09, 2026
Sustained disease remission after a limited duration of bispecific antibody therapy in patients with multiple myeloma.

Pageof 9

Frequent Collaborators

25 joint publications

Frits van Rhee

24 joint publications

Samer Al-Hadidi

17 joint publications

Meera Mohan

10 joint publications

Fenghuang Zhan